T. Rowe Price Investment Management, Inc. 13D and 13G filings for MoonLake Immunotherapeutics:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 10:39 am Purchase | 2026-06-30 | 13G | MOONLAKE IMMUNOTHERAPEUTICS CO MLTX | T. Rowe Price Investment Management, Inc. | 4,280,624 5.300% | 4,280,624 (New Position) | Filing |